- 英文名称
- Licogliflozin
- 分子式
- C23H28O7
- 分子量
- 416.46
- 中文别名
- (2S,3R,4R,5S,6R)-2-(3-((2,3-二氢苯并[b][1,4]dioxin-6-基)甲基)-4-乙基苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇; (2S,3R,4R,5S,6R)-2-(3-((2,3-二氢苯并[B][1,4]二恶英-6-基)甲基)-4-乙基苯基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇; LIK066; LIK-066; licogliflozina; licogliflozine; licogliflozinum; (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol; (1S)-1,5-Anhydro-1-C-[3-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-4-ethylphenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethyl)-4-ethyl-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
- 用途
- 化学合成;作为钠-葡萄糖协同转运蛋白 (SGLT1 和 SGLT2) 抑制剂,用于相关医药研究。